explore -WSS

explore

author：explore 2025-10-02 00:18:56 - browse：3

The Johnson and Johnson booth at ESMO in Madrid. — The Johnson & Johnson booth at ESMO 2023. Andrew Joseph/STAT

MADRID — A competition has been brewing between two pharma titans — Johnson & Johnson and AstraZeneca — to gain an edge in the market for targeted lung cancer treatments. A primetime presentation here Monday amounted to the latest salvo.

At the annual meeting of the European Society for Medical Oncology, J&J unveiled three studies of its drug Rybrevant in different patient groups with non-small cell lung cancer with EGFR mutations. All were successful, with the drug, sometimes used in combination with other therapies, helping stave off progression of the disease.

In an interview, Mark Wildgust, J&J’s vice president of global medical affairs for oncology, framed the totality of the research as a case that Rybrevant could become a regularly used treatment for these patients.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： A timeline of the missing Titanic tourist submersible

WSS

1 dead, 9 hurt in July 4th fireworks explosion

Biden administration sends mixed signals on US soldier who crossed into North Korea

Russians and Belarusians back at Wimbledon as war in Ukraine continues

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Manchin plays down potential 3rd

EU climate chief is concerned over the expansion of the coal industry in China

hotspot

explore

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Tori Bowie and the unacceptable rates of Black maternal death

PlayStation controller and acoustic messaging: How the missing Titanic tourist sub works

As demand for Covid shots wanes, Moderna seeks its next success

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Dobbs anniversary: the lost opportunity of abortion as health care

4 dead, 2 in stable condition in Philadelphia shooting: Police

Walensky prepares to leave CDC — and Congress — behind

FDA seeking to stop procedures at two unregulated stem cell clinics

hotspot

EU climate chief is concerned over the expansion of the coal industry in China

A timeline of the missing Titanic tourist submersible

Elon Musk announces 'temporary limits' for reading Twitter posts

15 die by electrocution after transformer explodes in northern India

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Greece's new parliament sworn in following conservative party's election victory

knowledge

entertainment

Wikipedia

knowledge